title: Vilazodone, levomilnacipran and vortioxetine for major depressive disorder: the 15-min challenge to sort these agents out.
authors: New York Medical College, Valhalla, NY, USA. citrome@cnsconsultant.com.
authors: L
authors: L
authors: Citrome
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003521:Cyclopropanes / Q000009:adverse effects / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D000078764:Milnacipran; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D013440:Sulfides / Q000009:adverse effects / Q000627:therapeutic use*; D000069503:Vilazodone Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use*; D000078784:Vortioxetine
chemical_list: D000928:Antidepressive Agents; D003521:Cyclopropanes; D010879:Piperazines; D013440:Sulfides; D000078784:Vortioxetine; D000078764:Milnacipran; D000069503:Vilazodone Hydrochloride